PMID- 11160041 OWN - NLM STAT- MEDLINE DCOM- 20010705 LR - 20171213 IS - 8750-7587 (Print) IS - 0161-7567 (Linking) VI - 90 IP - 2 DP - 2001 Feb TI - Glucose kinetics and substrate oxidation during exercise in the follicular and luteal phases. PG - 447-53 AB - The purpose of this investigation was to determine whether plasma glucose kinetics and substrate oxidation during exercise are dependent on the phase of the menstrual cycle. Once during the follicular (F) and luteal (L) phases, moderately trained subjects [peak O(2) uptake (V(O(2))) = 48.2 +/- 1.1 ml. min(-1). kg(-1); n = 6] cycled for 25 min at approximately 70% of the V(O(2)) at their respective lactate threshold (70%LT), followed immediately by 25 min at 90%LT. Rates of plasma glucose appearance (R(a)) and disappearance (R(d)) were determined with a primed constant infusion of [6,6-(2)H]glucose, and total carbohydrate (CHO) and fat oxidation were determined with indirect calorimetry. At rest and during exercise at 70%LT, there were no differences in glucose R(a) or R(d) between phases. CHO and fat oxidation were not different between phases at 70%LT. At 90%LT, glucose R(a) (28.8 +/- 4.8 vs. 33.7 +/- 4.5 micromol. min(-1). kg(-1); P < 0.05) and R(d) (28.4 +/- 4.8 vs. 34.0 +/- 4.1 micromol. min(-1). kg(-1); P < 0.05) were lower during the L phase. In addition, at 90%LT, CHO oxidation was lower during the L compared with the F phase (82.0 +/- 12.3 vs. 93.8 +/- 9.7 micromol. min(-1) .kg(-1); P < 0.05). Conversely, total fat oxidation was greater during the L phase at 90%LT (7.46 +/- 1.01 vs. 6.05 +/- 0.89 micromol. min(-1). kg(-1); P < 0.05). Plasma lactate concentration was also lower during the L phase at 90%LT concentrations (2.48 +/- 0.41 vs. 3.08 +/- 0.39 mmol/l; P < 0.05). The lower CHO utilization during the L phase was associated with an elevated resting estradiol (P < 0.05). These results indicate that plasma glucose kinetics and CHO oxidation during moderate-intensity exercise are lower during the L compared with the F phase in women. These differences may have been due to differences in circulating estradiol. FAU - Zderic, T W AU - Zderic TW AD - Human Performance Laboratory, University of Montana, Missoula, Montana 59812-1825, USA. FAU - Coggan, A R AU - Coggan AR FAU - Ruby, B C AU - Ruby BC LA - eng GR - AG-14769/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Appl Physiol (1985) JT - Journal of applied physiology (Bethesda, Md. : 1985) JID - 8502536 RN - 0 (Blood Glucose) RN - 0 (Fats) RN - 0 (Insulin) RN - 12629-01-5 (Human Growth Hormone) RN - 33X04XA5AT (Lactic Acid) RN - 4TI98Z838E (Estradiol) RN - PDC6A3C0OX (Glycerol) SB - IM MH - Adult MH - Blood Glucose/*metabolism MH - *Carbohydrate Metabolism MH - Estradiol/blood MH - *Exercise MH - Fats/metabolism MH - Female MH - Follicular Phase/blood/*metabolism MH - Glycerol/blood MH - Human Growth Hormone/blood MH - Humans MH - Insulin/blood MH - Kinetics MH - Lactic Acid/blood MH - Luteal Phase/blood/*metabolism MH - Oxidation-Reduction MH - Oxygen Consumption EDAT- 2001/02/13 11:00 MHDA- 2001/07/06 10:01 CRDT- 2001/02/13 11:00 PHST- 2001/02/13 11:00 [pubmed] PHST- 2001/07/06 10:01 [medline] PHST- 2001/02/13 11:00 [entrez] AID - 10.1152/jappl.2001.90.2.447 [doi] PST - ppublish SO - J Appl Physiol (1985). 2001 Feb;90(2):447-53. doi: 10.1152/jappl.2001.90.2.447.